Exemplis Discimus 2009, 153(2):125-129

Sed in lorem quis metus aliquam sollicitudin.

T'licl Yidratha, Ghent Amaviaa, Krig Onasia, Zerrak Rosta, Tai-San Mardinb
a National Institute of Dermato-venerology, Auril University, Malastare Republic
b 1st Clinic of Nursing Management, University Hospital of Orus, Republic of Yavin

Background: Vestibulum dolor lectus, convallis sit amet, mattis sit amet, tempor ut, mauris. Vivamus neque eros, tristique eu, lobortis sit amet, volutpat id, sem. Integer massa leo, porta dignissim, tempus eu, consectetuer nec, arcu. Nullam eu metus eu tellus sagittis volutpat. Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Pellentesque eget velit sed ante euismod iaculis. Sed magna felis, viverra in, pharetra at, sodales eu, ante. Nulla nulla mauris, sodales ac, cursus vitae, sagittis bibendum, tellus.

Methods: Morbi odio urna, auctor vitae, fermentum sit amet, consectetuer elementum, felis. Donec orci leo, pellentesque non, hendrerit vestibulum, tempor eu, libero.. Praesent mi risus, aliquam at, venenatis ac, bibendum at, arcu. Donec risus eros, rhoncus sit amet, aliquam in, fermentum vitae, est. Praesent purus odio, facilisis eget, luctus ac, mattis ac, felis. Vestibulum id lacus et purus aliquam iaculis. Fusce eget nunc id ante feugiat condimentum.. Proin turpis augue, laoreet sed, venenatis eu, dignissim eu, mauris.

Results: Etiam diam neque, dictum placerat, pulvinar et, rhoncus vitae, diam. Morbi tellus justo, suscipit sit amet, egestas a, consectetuer eu, ligula. Etiam pede neque, porttitor eu, rhoncus et, sodales et, ligula. Sed nisi arcu, aliquet at, iaculis eget, porta sit amet, tellus. Fusce mi pede, laoreet in, facilisis at, suscipit sed, magna. Duis lorem mi, consectetuer vel, consectetuer nec, suscipit quis, augue. Nam nulla lorem, pellentesque ac, sollicitudin id, pellentesque non, mauris. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus.

Conclusion: Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere cubilia Curae; Vivamus porttitor scelerisque libero. Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere cubilia Curae; Quisque fringilla est et lacus.

Kľúčové slová: Morbi elit, Integer vitae neque, Donec vitae purus, Aenean ipsum, Morbi in augue, Vestibulum augue

Vložený: January 22, 2009; Přijatý: March 15, 2009; Uverejnené: June 1, 2009 


Referencie

  1. Hudlicka O, Brown M & Egginton S . Angiogenesis in skeletal and cardiac muscle. Physiol Rev 1992; 72: 369417.
  2. Sandra Liekens, Erik De Clercq, Johan Neyts. Angiogenesis: regulators and clinical applications. Biochemical Pharmacology 2001; 61: 25370. Prejsť k pôvodnému zdroju...
  3. Nematbakhsh M, Ghadesi M, Hosseinbalam M, Khazaei M, Gharagozlo M, Dashti G, Rajabi P, Rafieian S. Oestrogen promotes coronary angiogenesis even under normoxic conditions. Basic Clin Pharmacol Toxicol. 2008;103(3):273-7. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  4. Namba T, Koike H, Murakami K, Aoki M, Makino H, Hashiya N, Ogihara T, Kaneda Y, Kohno M, Morishita R. Angiogenesis induced by endothelial nitric oxide synthase gene through vascular endothelial growth factor expression in a rat hindlimb ischemia model.Circulation 2003;108(18):2250-7. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  5. Sennlaub F, Courtois Y, Goureau O. Inducible nitric oxide synthase mediates the change from retinal to vitreal neovascularization in ischemic retinopathy. J Clin Invest 2001;107(6):717-25. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  6. Ziche M, Morbidelli L, Masini E, Amerini S, Granger HJ, Maggi CA, Geppetti P, Ledda F. Nitric oxide mediates angiogenesis invivo and endothelial cell growth and migration in vitro promoted by substanceP. J. Clin. Invest 1994; 94:203644. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  7. Murohara T, Asahara T, Silver M, Bauters C, Masuda H, Kalka C, Kearney M, Chen D, Symes JF, Fishman MC, Huang PL, Isner JM. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 1998; 101(11):2567-78. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  8. Fukumura D, Gohongi T, Kadambi A, Izumi Y, Ang J, Yun CO, Buerk DG, Huang PL, Jain RK. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci U S A 2001;98(5):2604-9. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  9. Sennlaub F, Courtois Y, Goureau O. Nitric oxide synthase-II is expressed in severe corneal alkali burns and inhibits neovascularization. Invest ophthalmol Vis Sci 1999;40(12):2773-9. Prejsť na PubMed...
  10. Chen Wl, Ouyang KX, Li HG, Huang ZQ, Li JS, Wang JG. Expression of Inducible Nitric Oxide Synthase andVascular Endothelial Growth Factor in Ameloblastoma. J Craniofacial Surgery 2009; 20 (1): 171-5. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  11. Gallo O, Masini E, Morbidelli L, Franchi A, Fini-Storchi I, Vergari WA, Ziche M. Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer. J Natl Cancer Inst 1998;90(8):587-96. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  12. Kane AJ, Barker JE, Mitchell GM, Theile DR, Romero R, Messina A, Wagh M, Fraulin FO, Morrison WA, Stewart AG. Inducible nitric oxide synthase (iNOS) activity promotes ischaemic skin flap survival. Br J Pharmacol 2001; 132(8):1631-8. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  13. Hirota K, Semenza GL. Regulation of angiogenesis by hypoxiainducible factor 1.Crit Rev Oncol Hematol 2006;59(1):15-26. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  14. Milkiewicz M, Pugh CW, Egginton S. Inhibition of endogenous HIF inactivation induces angiogenesis in ischaemic skeletal muscles of mice. J Physiol 2004 ;560(Pt 1):21-6. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  15. Akasaki Y, Miyata M, Eto H, Shirasawa T, Hamada N, Ikeda Y, Biro S, Otsuji Y, Tei C. Repeated thermal therapy up-regulates endothelial nitric oxide synthase and augments angiogenesis in a mouse model of hindlimb ischemia. Circ J. 2006;70(4):463-70. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  16. Namba T, Koike H, Murakami K, Aoki M, Makino H, Hashiya N, Ogihara T, Kaneda Y, Kohno M, Morishita R. Angiogenesis induced by endothelial nitric oxide synthase gene through vascular endothelial growth factor expression in a rat hindlimb ischemia model. Circulation. 2003;108(18):2250-7. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  17. Smith RS Jr, Lin KF, Agata J, Chao L, Chao J. Human endothelial nitric oxide synthase gene delivery promotes angiogenesis in a rat model of hindlimb ischemia. Arterioscler Thromb Vasc Biol. 2002 Aug 1;22(8):1279-85. Prejsť k pôvodnému zdroju...
  18. Lloyd PG, Yang HT, Terjung RL. Arteriogenesis and angiogenesis in rat ischemic hindlimb: role of nitric oxide Am J Physiol Heart Circ Physiol. 200;281(6):H2528-38.
  19. Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: structure, function and inhibition Biochem J. 2001;357(Pt 3):593- 615. Prejsť k pôvodnému zdroju...
  20. McCartney-Francis NL, Song X, Mizel DE, Wahl SM. Selective inhibition of inducible nitric oxide synthase exacerbates erosive joint disease. J Immunol. 2001;166(4):2734-40. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  21. Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, Zagzag D, Buechler P, Isaacs WB, Semenza GL, Simons JW. Over expression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res 1999;59(22):5830-5. Prejsť na PubMed...
  22. Milkiewicz M, Ispanovic E, Doyle JL, Haas TL. Regulators of angiogenesis and strategies for their therapeutic manipulation. Int J Biochem Cell Biol 2006;38(3):333-57. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  23. Lau YT, Ma WC. Nitric oxide inhibits migration of culturedendothelial cells. Biochem. Biophys. Res. Commun 1996; 221:6704. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  24. RayChaudhury A, Frischer H, Malik AB. Inhibition of endothelial cell proliferation and bFGF-induced phenotypic modulation by nitric oxide. J Cell Biochem 1996 ;63(2):125-34. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  25. Thomsen LL, Scott JM, Topley P, Knowles RG, Keerie AJ, Frend AJ. Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: studies with 1400W, a novel inhibitor. Cancer Res 1997;57(15):3300-4. Prejsť na PubMed...
  26. Donnini S, Ziche M. Constitutive and inducible nitric oxide synthase: role in angiogenesis.Antioxid Redox Signal 2002;4(5):817-23. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  27. Rhodes P, Leone AM, Francis PL, Struthers AD, Moncada S, Rhodes PM The L-argenin: nitric oxide pathway is the major source of plasma nitrite in fasted humans. Biochem Biophys Res Comm 1995; 209(2): 590-6. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  28. Ostendorf T, Van Roeyen C, Westenfeld R, Gawlik A, Kitahara M, De Heer E, Kerjaschki D, Floege J, Ketteler M. Inducible nitric oxide synthase derived nitric oxide promotes glomerular angiogenesis via upregulation of vascular egf receptors. J am soc Nephrol. 2003; 15(9): 2307-19. Prejsť k pôvodnému zdroju...
  29. Stenger S, Donhauser N, Thüring H, Röllinghoff M, Bogdan C. Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase. J Exp Med 1996; 183(4): 1501-14. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  30. Xie QW, Leung M, Fuortes M, Sassa S, Nathan C. Complementation analysis of mutants of nitric oxide synthase reveals that the active site requires two hemes. Proc Natl Acad Sci U S A 1996;93(10):4891-6. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  31. Bryk R, Wolff DJ. Mechanism of inducible nitric oxide synthase inactivation by aminoguanidine and L-N6-(1-iminoethyl)lysine. Biochemistry. 1998; 37(14):4844-52. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  32. Pipili-Synetos E, Kritikou S, Papadimitriou E, Athanassiadou A, Flordellis C, Maragoudakis ME. Nitric oxide synthase expression, enzyme activity and NO production during angiogenesis in the chick chorioallantoic membrane. Br J Pharmacol. 2000;129(1):207- 13. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  33. Kroll J. VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR). Biochem Biophys Res Commun 1998; 252: 743-6. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  34. Ichihara S, Yamada Y, Ichihara G, Nakajima T, Li P, Kondo T, Gonzalez FJ, Murohara T. A role for the aryl hydrocarbon receptor in regulation of ischemia-induced angiogenesis. Arterioscler Thromb Vasc Biol 2007;27(6):1297-304. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  35. Vincent KA, Shyu KG, Luo Y, Magner M, Tio RA, Jiang C, Goldberg MA, Akita GY, Gregory RJ, Isner JM. Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding an HIF-1alpha/VP16 hybrid transcription factor. Circulation 2000;102(18):2255-61. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  36. Patel TH, Kimura H, Weiss CR, Semenza GL, Hofmann LV. Constitutively active HIF-1alpha improves perfusion and arterial remodeling in an endovascular model of limb ischemia. Cardiovasc Res 2005;68(1):144-54. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  37. Blanco Pampín J, García Rivero SA, Otero Cepeda XL, Vázquez Boquete A, Forteza Vila J, Hinojal Fonseca R. Immunohistochemical expression of HIF-1 in response to early myocardial ischemia. J Forensic sci. 2006; 51(1): 120-4. Prejsť k pôvodnému zdroju... Prejsť na PubMed...